[1] |
Wang Jiani, Xi Mingxia.
Progress in catastrophic health expenditures for tuberculosis
[J]. Chinese Journal of Antituberculosis, 2024, 46(1): 112-118.
|
[2] |
Lyu Tong, Yang Yunbin, Pan Ying, Cheng Yuyu, Li Zichao, Xu Lin.
Analysis of economic burden and influencing factors of rifampin-resistant pulmonary tuberculosis in Yunnan Province
[J]. Chinese Journal of Antituberculosis, 2023, 45(11): 1031-1037.
|
[3] |
Chen Daiquan, Lin Shufang, Zhou Yinfa, Chen Kun, Dai Zhisong.
Patient delay and related factors among tuberculosis patient in Fujian Province, 2010—2019
[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 96-103.
|
[4] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, ZHOU Yin-fa, ZHANG Tian-lin, WEI Shu-zhen.
Analysis of the drug resistance surveillance results of Mycobacterium tuberculosis in Fujian Province from 2016 to 2019
[J]. Chinese Journal of Antituberculosis, 2021, 43(9): 924-928.
|
[5] |
ZHOU Yin-fa, LIN Shu-fang, DAI Zhi-song, Wei Shu-zhen, CHEN Dai-quan.
Temporal-spatial distribution of pulmonary tuberculosis in Fujian Province during 2011—2020
[J]. Chinese Journal of Antituberculosis, 2021, 43(8): 853-856.
|
[6] |
LIN Jian, LIN Shu-fang, DAI Zhi-song, ZHAO Yong, WEI Shu-zhen, ZHOU Yin-fa.
Study on the distribution and epidemiological characteristics of non-tuberculous mycobacterium strains in Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(5): 518-522.
|
[7] |
Jian-zhi LI,Jun LI,Ting REN,Ning LI.
Cost-benefit analysis of tuberculosis prevention and control program from 2006 to 2015 in Taian
[J]. Chinese Journal of Antituberculosis, 2018, 40(4): 429-433.
|
[8] |
DAI Shui qiong, PU Hong xue, ZHAO Zi hui, BA Li ying, LI Yin.
Analysis on costbenefit of tuberculosis prevention and control in Eshan county during the 12th five year plan
[J]. Chinese Journal of Antituberculosis, 2017, 39(3): 318-321.
|
[9] |
WANG Dong-mei,ZHANG Li-jie,LI Tao,JIANG Shi-wen,LIU Xiao-qiu,LI Jun,WANG Jia,WANG Li-xia,ZHANG Hui.
Resource allocation analysis of China Global Fund TB Program for Tuberculosis prevention and control
[J]. Chinese Journal of Antituberculosis, 2014, 36(10): 868-873.
|
[10] |
CHEN Qiu-yang,LIN Shu-fang, LIANG Qing-fu,WEI Shu-zhen,ZHAO Yong, LIN Jian, ZHENG Jin-feng.
Tuberculosis drug resistance surveillance report in Fujian province
[J]. Chinese Journal of Antituberculosis, 2013, 35(7): 511-515.
|
[11] |
LI Qiang, XIA Hui, OU Xi-chao, ZHAO Bing, PANG Yu, ZHAO Yan-lin.
Cost comparison analysis of line probe assay and conventional drug susceptibility testing for diagnosis of drug resistance of Mycobacteria tuberculosis
[J]. Chinese Journal of Antituberculosis, 2013, 35(3): 187-190.
|
[12] |
LIN Shu-fang, CHEN Qiu-yang, ZHENG Jin-feng, WEI Shu-zhen, DAI Zhi-song, LIN Yong-ming.
The evaluation of implementation effect of tuberculosis control program in Fujian province during 2001—2010
[J]. Chinese Journal of Antituberculosis, 2013, 35(1): 65-69.
|
[13] |
SUN Yan-ni, WANG Guo-jie, ZHEN Xin-an, LIU Zhan-feng, Harley David, Hall Gillian, Vally Hassan, Sleigh Adrian..
The economic status and treatment cost of MDR-TB patients compared to nonMDR-TB patients in Henan province
[J]. Chinese Journal of Antituberculosis, 2012, 34(12): 773-779.
|
[14] |
WU Lai-wa, YAN Fei, WANG Wei, JIA Huan, SHEN Xin, MEI Jian.
Analysis on direct medical expenses and its financial burden of pulmonary tuberculosis patients in Shanghai
[J]. Chinese Journal of Antituberculosis, 2012, 34(10): 664-669.
|
[15] |
Chen Jing1, Wei Xiaolin, Li Hongdi, Sun Chenguang, Zhang Zeshen, Chen Ping, Shen Mei, Mei Jian.
Study on barriers to anti-TB treatment for rural-to-urban migrant TB patients in Shanghai
[J]. Chinese Journal of Antituberculosis, 2009, 31(6): 337-340.
|